LIT-001 is a small-molecule oxytocin receptor agonist and vasopressin receptor mixed agonist and antagonist that was first described in the literature...
8 KB (696 words) - 04:21, 22 July 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
17 KB (1,518 words) - 18:20, 7 November 2023
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
10 KB (584 words) - 08:21, 8 March 2024
small-molecule oxytocin receptor agonists, like TC OT 39, WAY-267464, and LIT-001 have been developed and studied. However, lack of selectivity over vasopressin...
34 KB (3,243 words) - 23:32, 5 August 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
11 KB (763 words) - 16:45, 26 June 2024
Progress in Neurobiology. 88 (2): 127–151. doi:10.1016/j.pneurobio.2009.04.001. PMC 2689929. PMID 19482229. Ott I, Scott JC (1910). "The action of infundibulin...
104 KB (11,649 words) - 03:28, 28 July 2024
Suppl 1): S1–21. CiteSeerX 10.1.1.499.7585. doi:10.1016/j.amjmed.2007.09.001. PMID 17981159. Young LJ (October 2009). "The neuroendocrinology of the social...
45 KB (4,138 words) - 08:56, 17 July 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
30 KB (2,641 words) - 15:20, 20 June 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
20 KB (2,321 words) - 00:01, 15 May 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
18 KB (1,708 words) - 23:36, 23 July 2024
small-molecule oxytocin receptor agonists like TC OT 39, WAY-267464, and LIT-001. Oxytocin receptor agonists are used medically to induce labor, promote...
3 KB (269 words) - 03:16, 29 July 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
13 KB (1,043 words) - 10:45, 11 February 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
10 KB (1,059 words) - 05:14, 3 June 2024
other personality disorders. Oxytocin receptor agonists, like oxytocin and LIT-001, are of theoretical interest in the potential medical treatment of social...
2 KB (186 words) - 14:28, 3 December 2023
Trends in Pharmacological Sciences. 40 (1): 22–37. doi:10.1016/j.tips.2018.11.001. hdl:1959.4/unsworks_81554. PMID 30509888. S2CID 54559394. Portal: Medicine...
21 KB (1,918 words) - 04:36, 22 July 2024
Biobehavioral Reviews. 35 (3): 804–817. doi:10.1016/j.neubiorev.2010.10.001. PMID 20934453. S2CID 11421586. York JD, Ponder JW, Majerus PW (May 1995)...
92 KB (9,837 words) - 17:29, 28 July 2024
Carbetocin Demoxytocin Lipo-oxytocin-1 Merotocin Oxytocin Non-peptide LIT-001 — improved social deficits in mice; non-selective over vasopressin receptors...
22 KB (2,497 words) - 03:15, 29 July 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
25 KB (2,496 words) - 15:39, 20 December 2023
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
8 KB (805 words) - 13:07, 26 July 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
11 KB (974 words) - 03:10, 10 March 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
3 KB (407 words) - 06:08, 27 March 2022
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
6 KB (363 words) - 07:00, 21 April 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
3 KB (165 words) - 15:54, 3 June 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
3 KB (130 words) - 05:20, 30 May 2016
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
4 KB (457 words) - 18:49, 21 March 2021
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
15 KB (1,740 words) - 11:59, 4 January 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
11 KB (1,361 words) - 06:01, 27 August 2023
Evolution & Human Behavior. 36 (2): 130–136. doi:10.1016/j.evolhumbehav.2014.10.001. Walum H, Westberg L, Henningsson S, Neiderhiser JM, Reiss D, Igl W, Ganiban...
29 KB (3,516 words) - 03:58, 16 July 2024
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
8 KB (536 words) - 19:18, 8 December 2023
PF-06478939 PF-06655075 (PF1) TGOT Vasotocin (argiprestocin); Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid;...
15 KB (1,682 words) - 20:17, 16 July 2024